Related Experiment Video
Updated: Mar 19, 2026

Establishment of an Extracellular Acidic pH Culture System
Published on: November 19, 2017
Impact of acetylation on tumor metabolism
Di Zhao1, Fu-Long Li1, Zhou-Li Cheng1
1Key Laboratory of Molecular Medicine; Ministry of Education, and Department of Biochemistry and Molecular Biology; Fudan University Shanghai Medical College; Shanghai, People's Republic of China; Molecular and Cell Biology Lab; Institutes of Biomedical Sciences; Fudan University; Shanghai, People's Republic of China.
Abstract:
Acetylation of protein lysine residues is a reversible and dynamic process that is controlled by histone acetyltransferases (HATs) and deacetylases (HDACs and SIRTs). Recent studies have revealed that acetylation modulates not only nuclear proteins but also cytoplasmic or mitochondrial proteins, including many metabolic enzymes. In tumors, cellular metabolism is reprogrammed to provide intermediates for biosynthesis such as nucleotides, fatty acids, and amino acids, and thereby favor the rapid proliferation of cancer cells and tumor development. An increasing number of investigations have indicated that acetylation plays an important role in tumor metabolism. Here, we summarize the substrates that are modified by acetylation, especially oncogenes, tumor suppressor genes, and enzymes that are implicated in tumor metabolism.
Insights
Protein acetylation, regulated by HATs and HDACs/SIRTs, impacts nuclear and metabolic proteins. This review highlights acetylation
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Protein acetylation is a dynamic post-translational modification.
- Acetylation affects nuclear, cytoplasmic, and mitochondrial proteins, including metabolic enzymes.
- Tumor cells reprogram metabolism to support proliferation.
Purpose of the Study:
- To review substrates modified by acetylation.
- To focus on acetylation's role in tumor metabolism.
- To highlight acetylation of oncogenes, tumor suppressors, and metabolic enzymes.
Main Methods:
- Literature review and synthesis.
- Analysis of existing research on protein acetylation.
- Focus on studies implicating acetylation in cancer metabolism.
Main Results:
- Acetylation modifies numerous proteins, including key players in cancer.
- Specific acetylation targets include oncogenes, tumor suppressor genes, and metabolic enzymes.
- Dysregulated acetylation contributes to altered tumor metabolism.
Conclusions:
- Acetylation is a critical regulator of tumor metabolism.
- Targeting acetylation pathways may offer novel cancer therapies.
- Further research is needed to fully elucidate acetylation's role in oncogenesis.
Related Concept Videos
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
The Tumor Microenvironment

